May 22, 2023, ADMA Biologics Inc. (NASDAQ: ADMA) trading session started at the price of $4.12, that was 1.22% jump from the session before. During the day, the shares moved up to $4.20 and dropped to $4.095 before settling in for the closing price of $4.10. A 52-week range for ADMA has been $1.82 – $4.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 46.60%. When this article was written, the company’s average yearly earnings per share was at 35.10%. With a float of $176.84 million, this company’s outstanding shares have now reached $221.92 million.
Let’s determine the extent of company efficiency that accounts for 617 employees. In terms of profitability, gross margin is +22.42, operating margin of -25.69, and the pretax margin is -42.91.
ADMA Biologics Inc. (ADMA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ADMA Biologics Inc. stocks. The insider ownership of ADMA Biologics Inc. is 1.50%, while institutional ownership is 67.30%. The most recent insider transaction that took place on Dec 09, was worth 42,851. In this transaction President and CEO of this company bought 14,983 shares at a rate of $2.86, taking the stock ownership to the 2,203,708 shares. Before that another transaction happened on Dec 09, when Company’s President and CEO bought 14,982 for $2.86, making the entire transaction worth $42,849. This insider now owns 1,143,426 shares in total.
ADMA Biologics Inc. (ADMA) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 3/30/2023, it has been observed that the corporation posted -$0.03 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.04) by $0.01. This company achieved a net margin of -42.77 while generating a return on equity of -44.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 35.10% per share during the next fiscal year.
ADMA Biologics Inc. (NASDAQ: ADMA) Trading Performance Indicators
You can see what ADMA Biologics Inc. (ADMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.24, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.07 in one year’s time.
Technical Analysis of ADMA Biologics Inc. (ADMA)
Looking closely at ADMA Biologics Inc. (NASDAQ: ADMA), its last 5-days average volume was 2.11 million, which is a drop from its year-to-date volume of 2.46 million. As of the previous 9 days, the stock’s Stochastic %D was 76.48%. Additionally, its Average True Range was 0.17.
During the past 100 days, ADMA Biologics Inc.’s (ADMA) raw stochastic average was set at 88.93%, which indicates a significant increase from 85.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.98% in the past 14 days, which was higher than the 48.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.42, while its 200-day Moving Average is $3.17. However, in the short run, ADMA Biologics Inc.’s stock first resistance to watch stands at $4.20. Second resistance stands at $4.25. The third major resistance level sits at $4.31. If the price goes on to break the first support level at $4.10, it is likely to go to the next support level at $4.04. Should the price break the second support level, the third support level stands at $3.99.
ADMA Biologics Inc. (NASDAQ: ADMA) Key Stats
There are 222,273K outstanding shares of the company, which has a market capitalization of 908.93 million. As of now, sales total 154,080 K while income totals -65,900 K. Its latest quarter income was 56,910 K while its last quarter net income were -6,790 K.
